Dow Down 0.92% Nasdaq Down 0.83%

Antares Pharma Inc. (ATRS)

-NasdaqCM
1.98 Down 0.02(1.00%) 4:00PM EDT
Prev Close:2.00
Open:2.01
Bid:1.95 x 100
Ask:2.00 x 100
1y Target Est:5.63
Beta:1.41
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.97 - 2.08
52wk Range:1.82 - 5.01
Volume:1,231,800
Avg Vol (3m):1,120,510
Market Cap:258.33M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ATRS

Comparison

Symbol% ChgMkt Cap
ATRSDown 1.00%258.33M
BDXUp 0.33%23.73B
BJCTUp 9.03%5.82M

Key Statistics

Forward P/E (1 yr):33.00
P/S (ttm):11.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback